Burleson & Company, LLC Pfizer Inc Transaction History

Burleson & Company, LLC

$384 Million
Q4 2022

A detailed history of Burleson & Company, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Burleson & Company, LLC holds 48,470 shares of PFE stock, worth $1.36 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

48,470

Previous 22,662 113.88%

Holding current value

$1.36 Million

Previous $992,000 150.4%

% of portfolio

0.65%

Previous 0.21%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	BUY	$41.75 - $54.5 $1.08 Million - $1.41 Million	25,808 Added 113.88%	48,470 $2.48 Million
Q3 2022 Oct 17, 2022	BUY	$43.76 - $53.42 $204,621 - $249,791	4,676 Added 26.0%	22,662 $992,000
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $2,186 - $2,592	47 Added 0.26%	17,986 $943,000
Q1 2022 Apr 25, 2022	SELL	$45.75 - $56.69 $18,757 - $23,242	-410 Reduced 2.23%	17,939 $929,000
Q4 2021 Jan 25, 2022	BUY	$41.32 - $61.25 $1,198 - $1,776	29 Added 0.16%	18,349 $1.08 Million

Q3 2021 Nov 02, 2021	BUY	$39.25 - $50.42 $6,672 - $8,571	170 Added 0.94%	18,320 $788,000
Q2 2021 Jul 22, 2021	BUY	$35.91 - $40.68 $77,816 - $88,153	2,167 Added 13.56%	18,150 $711,000
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $2,578 - $2,908	-77 Reduced 0.48%	15,983 $579,000
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $9,338 - $11,874	279 Added 1.77%	16,060 $591,000
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $158,019 - $185,393	-4,977 Reduced 23.98%	15,781 $574,000
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $26,746 - $32,447	-888 Reduced 4.1%	20,758 $798,000
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $65,736 - $93,923	-2,432 Reduced 10.1%	21,646 $806,000
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $592 - $672	18 Added 0.07%	24,078 $968,000
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $617 - $800	19 Added 0.08%	24,060 $885,000
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $591 - $664	16 Added 0.07%	24,041 $920,000
Q1 2019 May 09, 2019	BUY	$37.5 - $41.2 $600 - $659	16 Added 0.07%	24,025 $994,000
Q4 2018 Feb 27, 2019	SELL	$38.47 - $43.86 $196,312 - $223,817	-5,103 Reduced 17.53%	24,009 $1.01 Million
Q3 2018 Dec 06, 2018	BUY	$34.47 - $41.81 $163,801 - $198,681	4,752 Added 19.51%	29,112 $1.29 Million
Q2 2018 Jul 31, 2018	BUY	$32.98 - $35.16 $43,764 - $46,657	1,327 Added 5.76%	24,360 $884,000
Q1 2018 Apr 23, 2018	BUY	$31.91 - $37.02 $44,705 - $51,865	1,401 Added 6.48%	23,033 $817,000
Q4 2017 Mar 19, 2018	BUY	$33.26 - $35.29 $719,480 - $763,393	21,632	21,632 $784,000

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burleson & Company, LLC with notifications on news.

Account

Burleson & Company, LLC Pfizer Inc Transaction History